Table 2. Diabetes in relation to hepatocellular carcinoma (HCC) in total subjects, males and females separately, and by duration of diabetes prior to baseline interivew, Singapore Chinese Health Study 1993–2010.
Total number N (%) | HCC cases | HR (95% CI)a | HR (95% CI)b | |
---|---|---|---|---|
All | ||||
Non-diabetics | 55 852 (91.1) | 412 | 1.00 | 1.00 |
Diabetics |
5469 (8.9) |
87 |
2.64 (2.09–3.33) |
2.14 (1.69–2.71) |
Men | ||||
Non-diabetics | 24 933 (91.4) | 303 | 1.00 | 1.00 |
Diabetics |
2360 (8.6) |
58 |
2.51 (1.89–3.32) |
2.11 (1.58–2.81) |
Women | ||||
Non-diabetics | 30 919 (90.9) | 109 | 1.00 | 1.00 |
Diabetics |
3109 (9.1) |
29 |
3.27 (2.17–4.92) |
2.14 (1.41–3.25) |
Number of years of diabetes diagnosed prior to baseline interview | ||||
Non-diabetics | 55 852 (91.1) | 412 | 1.00 | 1.00 |
<5 years | 2139 (3.5) | 39 | 2.80 (2.01–3.89) | 2.41 (1.73–3.35) |
5–10 years | 1341 (2.2) | 21 | 2.53 (1.63–3.92) | 2.14 (1.38–3.33) |
⩾10 years | 1989 (3.2) | 27 | 2.52 (1.7–3.71) | 1.84 (1.24–2.72) |
Crude hazard ratio.
Adjusted for age, year of recruitment, gender, dialect group, level of education, cigarette smoking status, alcohol intake frequency, body mass index, and consumption of coffee and tea; HR, hazard ratio; CI, confidence interval.